Literature DB >> 2534160

Vitamin E concentrations in human brain of patients with Alzheimer's disease, fetuses with Down's syndrome, centenarians, and controls.

T Metcalfe1, D M Bowen, D P Muller.   

Abstract

The concentration of vitamin E (alpha-tocopherol) was measured in samples of cortex from patients with Alzheimer's disease (AD), fetuses with Down's syndrome (DS), and also in a group of centenarians. The mean tocopherol concentrations in the two patient groups did not differ significantly from appropriate controls. When expressed per lipid the mean tocopherol concentration of the centenarians was greater than that of the controls but this reflected a significant decrease in the lipid concentration of the former group. These results indicate that neither the normal aging processes, Alzheimer's disease, nor the increased in vitro lipid peroxidation reported in fetuses with Down's syndrome result from a gross lack of alpha-tocopherol, or cause a significant depletion of the vitamin.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2534160     DOI: 10.1007/bf00965511

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  19 in total

1.  A simplified spectrophotometric determination of ester groups in lipids.

Authors:  F SNYDER; N STEPHENS
Journal:  Biochim Biophys Acta       Date:  1959-07

2.  Vitamin E (tocopherol) in human fetuses and placentae.

Authors:  M Y DJU; K E MASON; L J FILER
Journal:  Etudes Neonatales       Date:  1952-09

3.  Quantitative growth and development of human brain.

Authors:  J Dobbing; J Sands
Journal:  Arch Dis Child       Date:  1973-10       Impact factor: 3.791

Review 4.  Down's syndrome, aging, and Alzheimer's disease: a clinical review.

Authors:  I T Lott
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

5.  Demential syndromes and the lipid metabolism.

Authors:  J Clausen
Journal:  Acta Neurol Scand       Date:  1984-11       Impact factor: 3.209

6.  Plaques, tangles and dementia. A quantitative study.

Authors:  G K Wilcock; M M Esiri
Journal:  J Neurol Sci       Date:  1982-11       Impact factor: 3.181

7.  Lack of tocopherol in peripheral nerves of vitamin E-deficient patients with peripheral neuropathy.

Authors:  M G Traber; R J Sokol; S P Ringel; H E Neville; C A Thellman; H J Kayden
Journal:  N Engl J Med       Date:  1987-07-30       Impact factor: 91.245

Review 8.  Vitamin E and the nervous system.

Authors:  A E Harding
Journal:  Crit Rev Neurobiol       Date:  1987

9.  Vitamin E and neurological function.

Authors:  D P Muller; J K Lloyd; O H Wolff
Journal:  Lancet       Date:  1983-01-29       Impact factor: 79.321

10.  Is vitamin E the only lipid-soluble, chain-breaking antioxidant in human blood plasma and erythrocyte membranes?

Authors:  G W Burton; A Joyce; K U Ingold
Journal:  Arch Biochem Biophys       Date:  1983-02-15       Impact factor: 4.013

View more
  12 in total

Review 1.  Tocopherol (vitamin E) in Alzheimer's disease and other neurodegenerative disorders.

Authors:  Karen Berman; Henry Brodaty
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

Review 2.  Systemic and brain metabolic dysfunction as a new paradigm for approaching Alzheimer's dementia.

Authors:  Vincenzo Giordano; Gianfranco Peluso; Maurizio Iannuccelli; Paola Benatti; Raffaella Nicolai; Menotti Calvani
Journal:  Neurochem Res       Date:  2006-08-17       Impact factor: 3.996

Review 3.  Role of free radicals in the neurodegenerative diseases: therapeutic implications for antioxidant treatment.

Authors:  B Halliwell
Journal:  Drugs Aging       Date:  2001       Impact factor: 3.923

4.  Concentrations of vitamins A and E in amniotic fluid, extraembryonic coelomic fluid, and maternal serum in the first trimester of pregnancy.

Authors:  J Campbell; N C Wathen; I Merryweather; R Abbott; D Muller; T Chard
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1994-07       Impact factor: 5.747

5.  Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease.

Authors:  F J Jiménez-Jiménez; F de Bustos; J A Molina; J Benito-León; A Tallón-Barranco; T Gasalla; M Ortí-Pareja; F Guillamón; J C Rubio; J Arenas; R Enríquez-de-Salamanca
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

6.  Lipid peroxidation and electrogenic ion transport in the jejunum of the vitamin E deficient rat.

Authors:  K J Lindley; M A Goss-Sampson; D P Muller; P J Milla
Journal:  Gut       Date:  1994-01       Impact factor: 23.059

7.  Supplementation with antioxidants and folinic acid for children with Down's syndrome: randomised controlled trial.

Authors:  Jill M Ellis; Hooi Kuan Tan; Ruth E Gilbert; David P R Muller; William Henley; Robert Moy; Rachel Pumphrey; Cornelius Ani; Sarah Davies; Vanessa Edwards; Heather Green; Alison Salt; Stuart Logan
Journal:  BMJ       Date:  2008-02-21

Review 8.  Glutathione in the Brain.

Authors:  Koji Aoyama
Journal:  Int J Mol Sci       Date:  2021-05-09       Impact factor: 5.923

Review 9.  Inhibition of GTRAP3-18 may increase neuroprotective glutathione (GSH) synthesis.

Authors:  Koji Aoyama; Toshio Nakaki
Journal:  Int J Mol Sci       Date:  2012-09-20       Impact factor: 6.208

Review 10.  Impaired glutathione synthesis in neurodegeneration.

Authors:  Koji Aoyama; Toshio Nakaki
Journal:  Int J Mol Sci       Date:  2013-10-18       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.